Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opened, Multicenter, Randomized, in Parallel Groups Comparative Study to Assess Efficacy and Safety of Dioxidin®, Solution for Topical and External Application 0.025% (Valenta Farm, Russia) and Miramistin®, Solution for Topical Application 0.01% (Infamed K LLC, Russia) in Treatment of Superficial Pyoderma

NCT05561816 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT05561816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05561816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opened, Multicenter, Randomized, in Parallel Groups Comparative Study to Assess Efficacy and Safety of Dioxidin®, Solution for Topical and External Application 0.025% (Valenta Farm, Russia) and Miramistin®, Solution for Topical Application 0.01% (Infamed K LLC, Russia) in Treatment of Superficial Pyoderma
Lead sponsor
Valenta Pharm JSC
Phase
Phase 3
Overall status
Completed
Start date
July 19, 2022
Completion date
December 20, 2022
Enrollment
240 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma